Immunome, Inc. Common Stock (NASDAQ: IMNM) last traded at $28.52, up 1.57% on the session. The quote above updates while this page is open; the figures below are drawn from Immunome, Inc. Common Stock’s own filings and are restated only when a new one is published.
Immunome, Inc. Common Stock trades on NASDAQ under the ticker IMNM. Its market capitalisation is $3.24 billion.
Valuation measures for Immunome, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $3.24B |
|---|---|
| Enterprise value | $3.06B |
| Price / book | 6.17 |
| Beta | 1.70 |
Trailing-twelve-month figures tagged in Immunome, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $0.00 |
|---|---|
| Net income (TTM) | -$254.32M |
| EPS (TTM) | -$2.54 |
| Return on equity | -48.43% |
| Cash | $217.71M |
Range and volume for IMNM over the past 52 weeks.
| 52-week high | $30.06 |
|---|---|
| 52-week low | $8.67 |
| Volume | 846.1K |
| Average volume | 1.39M |
| Previous close | $28.08 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.